Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation - STAT News

Retrieved on: 2022-08-03 08:49:19

Tags for this article:

Health sciences

Health

Design of experiments

Food and Drug Administration

Clinical trial

Orphan drug

Health equity

Pharmaceutical industry

United States

Click the tags to see associated articles and topics

Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation - STAT News. View article details on HISWAI: https://www.statnews.com/2022/08/03/lack-of-diversity-in-clinical-trials-costs-billions-of-dollars-incentives-can-spur-innovation/

Excerpt

These include lack of access to effective medical interventions, compounding of health disparities in underrepresented and excluded populations, and ...

Article found on: www.statnews.com

View Original Article